Quick Answer
Arcutis Biotherapeutics, Inc. reported Net Income of -$16.14 million for fiscal year 2025.
Arcutis Biotherapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$16.14M | +88.5% |
| 2024 | -$140.04M | +46.6% |
| 2023 | -$262.14M | +15.8% |
| 2022 | -$311.46M | -50.9% |
| 2021 | -$206.36M | -52.1% |
| 2020 | -$135.68M | -223.1% |
| 2019 | -$42.00M | -118.1% |
| 2018 | -$19.25M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.41M | +117.8% | +146.6% |
| June 30, 2025 | -$15.89M | +69.6% | +36.6% |
| March 31, 2025 | -$25.06M | +29.2% | +39.7% |
| September 30, 2024 | -$41.54M | +7.2% | +20.6% |
| June 30, 2024 | -$52.33M | +26.3% | -47.9% |
| March 31, 2024 | -$35.38M | +55.8% | +21.0% |
| September 30, 2023 | -$44.77M | +58.4% | +36.9% |
| June 30, 2023 | -$70.99M | -5.3% | +11.4% |
- Arcutis Biotherapeutics, Inc. showed an increase of +88.5% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Arcutis Biotherapeutics, Inc.’s net income has grown by 16.2% (from -$19.25 million to -$16.14 million).
- The most recent figure is from Arcutis Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: